People are running their own experiments with GLP-1s — with stunning results
GLP-1 drugs like Ozempic and Wegovy, originally developed for diabetes, are now being used by an estimated one in eight U.S. adults, primarily for weight loss but increasingly for unapproved conditions such as addiction, long COVID, and post-concussion syndrome. Journalist Julia Belluz ex
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Julia Belluz
conversational on Apple News Today
Mentions
Books, people, and resources mentioned in this episode.
People
Books
Companies
Products & Tools
Topics
Listen to This Episode
More from Apple News Today
Medicare will cover weight-loss drugs — but there’s a catch
Rebroadcast: The truth about Johnson & Johnson
Why men are suddenly so worried about their testosterone levels
Forever chemicals are hiding everywhere. These five habits can help you avoid them. (From the archives)
The real reason so many Americans are convinced sunscreen is dangerous
The questions mounting for Maine’s Democratic Senate front-runner
Related episodes
From other shows on similar topics.
Skinny and sad on GLP-1s
Today, Explained
Reshaping the GLP-1 Economy: A Breaking Consumer Study
We Fixed It, You're Welcome
What we got wrong about GLP-1s
Search Engine
Ozempic for All?
The Daily
How Big Food Is Navigating the GLP-1 Era
The Journal.
Rethinking addiction in the age of Ozempic
TED Radio Hour
Get summaries like this every morning.
Free AI-powered recaps of Apple News Today and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.